GP
Galmed Pharmaceuticals Ltd
🇺🇸XNAS.GLMDUnited StatesHealthcare
$3.57USDdown -0.06 (-1.65%)ClosedEnd of day1:50 AM
Price$3.57-0.06 (-1.65%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- IL0011313900
- CUSIP
- M47238106
Company
- Employees
- 3
- Headquarters
- Ramat Gan, United States
- Website
- https://galmedpharma.com
- CEO
- Mr. Allen Baharaff
Market
- Shares outstanding
- 1.1M
- Market cap
- $3.81M
Highlights
- Market cap
- $4.08M
- EPS LTM
- -$14.97
- P/E LTM
- -0.04
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$14.25M-63.39%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$7.95M-45.43%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.